Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shree Pacetronix's EBIT per Share for the
three
months ended in Mar. 2026 was ₹3.95.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹12.72.
During the past 12 months, the average EBIT per Share Growth Rate of Shree Pacetronix was 190.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -4.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 35.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Shree Pacetronix's EBIT per Share or its related term are showing as below:
BOM:527005'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -22.7 Med: 6.95 Max: 103.8
Current: -4.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shree Pacetronix was 103.80% per year. The lowest was -22.70% per year. And the median was 6.95% per year.
BOM:527005's 3-Year EBIT Growth Rate is ranked worse than 69.15% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs BOM:527005: -4.40
Shree Pacetronix (BOM:527005) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Shree Pacetronix EBIT per Share Related Terms
Shree Pacetronix EBIT per Share Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹12.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix (BOM:527005) has a EBIT per Share of ₹12.72 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shree Pacetronix and its competitors. According to the industry distribution chart, Shree Pacetronix ranks #473 out of 684 companies in the Medical Devices & Instruments industry, placing it in the top 69.2%.
Is Shree Pacetronix's EBIT per Share too high?
Shree Pacetronix's current EBIT per Share is ₹12.72. Based on the distribution chart, Shree Pacetronix ranks #473 out of 684 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shree Pacetronix has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #473 out of 684 companies for EBIT per Share. This places Shree Pacetronix in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shree Pacetronix and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current EBIT per Share is ₹12.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹163.37, compared to a current price of ₹128.05 — trading 21.6% below its estimated fair value. The current EBIT per Share is ₹12.72. Shree Pacetronix's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current EBIT per Share is ₹12.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹128.05 is trading 21.6% below its estimated GF Value™ of ₹163.37.
GuruFocus considers Shree Pacetronix to be Modestly Undervalued.
Key valuation signals for BOM:527005:
EBIT per Share: ₹12.72
GF Value™: ₹163.37 vs. price of ₹128.05 (21.6% below fair value)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
84GF Score
Get the complete analysis for BOM:527005
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
